LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Overview Fund Activity
Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

51 hedge funds and large institutions have $97.5M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 3 closing their positions.

Holders
51
Holders Change
+8
Holders Change %
+18.6%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$574K
2
JG
2
Jefferies Group
New York
$308K
3
Russell Investments Group
3
Russell Investments Group
United Kingdom
$250K
4
BlackRock
4
BlackRock
New York
$6.54M
5
TRCT
5
Tower Research Capital (TRC)
New York
$108K

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
BCM
2
Bridgeway Capital Management
Texas
$766K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$2.91M
4
SC
4
Samlyn Capital
New York
$7.03M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Adage Capital Partners
51
Adage Capital Partners
Massachusetts
– -$6.77M -800,000 Closed
First Trust Advisors
52
First Trust Advisors
Illinois
– -$111K -13,110 Closed
SO
53
STRS Ohio
Ohio
– -$18K -2,200 Closed
1 2
3